GSK science chief to depart as pharma giant looks to revamp drugs pipeline January 19, 2022 GlaxoSmithKline's chief scientific officer Hal Barron will leave the firm this year to join a Silicon Valley anti-ageing start up.
Strong jobs market print fails to dampen inflation fears on London markets January 18, 2022 Inflation jitters spreading throughout the City led London markets sharply lower today. The capital’s premier FTSE 100 dipped below the 7,600 mark by closing the day down 0.63 per cent, while the domestically-focused FTSE 250 fell 0.96 per cent to 22,652.71 points. Figures released by the Office for National Statistics (ONS) today revealed the unemployment [...]
Credit Suisse’s scalped chairman lays bare the new rules of post-purpose business January 18, 2022 Perhaps it’s time for an amnesty. All those in prominent positions in public life who flouted a lockdown rule here or there should fess up in return for a short, sharp rebuke from Sue Gray and no further repercussions. No doubt the prime minister would welcome such a resolution. But it would come too late [...]
FTSE 100 breaks another post-lockdown record by breaching 7,600 mark January 17, 2022 London’s premier index smashed another post-lockdown record yesterday in a sign investors are looking through the Covid-19 crisis. The FTSE 100 closed 0.91 per cent higher yesterday, breaching the 7,600 mark for the first time since January 2020. Sentiment was boosted by international investors waking up to the fact that large swathes of companies listed [...]
Bankers prepare £25bn package as private equity firms circle GSK January 17, 2022 Bankers are putting together major financing packages in preparation of a potential private equity bid for GlaxoSmithKline’s consumer healthcare business.
‘Marmite situation’ for GSK investors as Unilever bids spark potential bidding war January 17, 2022 Analysts have predicted a potential bidding war erupting for GSK’s consumer arm.
Unilever share price dives 7 per cent as £50bn battle for GlaxoSmithKline’s consumer business begins in earnest January 17, 2022 The main City story this morning is the £50bn bid by Unilever for GlaxoSmithKline’s consumer healthcare business, of which it owns a 68 per cent stake along with Pfizer, which Glaxo said it had rejected. “No doubt in the hope that Unilever will come back with a higher offer, with the sum of £60bn being [...]
Unilever offer for GSK consumer arm is short by £5bn say analysts January 17, 2022 Unilever’s rejected £50bn offer for Glaxo Smith Kline’s (GSK) consumer business falls short according to market analysts. Marmite maker Unilever has had three unsolicited offers rebuffed by GSK including a bid made last month which comprised of £41.7bn in cash and £8.3bn in company shares. Analysts have questioned the financial reasoning behind Unilever’s bid with [...]
Unilever makes £50bn bid for GSK’s consumer business January 15, 2022 Unilever has confirmed reports it made an unsolicited £50bn bid to snap up Glaxo Smith Kline's (GSK) consumer goods business.
Letters: Time to learn you E-S-Gs January 14, 2022 [Re: Terry Smith has a point – and the rest of the City should listen too, yesterday] Andy Silvester wrote how Terry Smith, one of Unilever’s top shareholders, “has a point” when saying the company has “lost the plot” with its focus on sustainability. Mr Smith told Fundsmith investors this week that Unilever has become [...]